SHERP

Parkisnon 증후군에 있어서의 Bromocriptine의 치료효과에 관한 연구
Therapeutic Effects of Bromocriptine in Idiopathic Parkinsonism

Cited 0 time in webofscience Cited 0 time in scopus
Authors
이문규; 민헌기; 이상복
Issue Date
1984-06
Publisher
서울대학교 의과대학
Citation
Seoul J Med 1984;25(2):201-208
Abstract
Therapeutic eκects of bromocriptine were evaluated
in 16 idiopathic Parkinsonism patients. 22.5mg of
bromocriptine was added to the conventional antiparkinsonian
agents including L-dopa, and clinical
evaluation was performed according to the Northwestern
University Disability Scales(NUDS) & Physical
Eximination Disability Scales(PEDS). Both
NUDS and PEDS showed a significant improvement
in score after bromocriptine therapy, especially in
walking, speech, tremor and finger dexterity. The
eight responders had taken significantly larger doses
of L-dopa and shorter periods of L-dopa treatment
than non-responders.
Bromocriptine showed a therapeutic effect as an
adjuvant to the L-dopa in idiopathic Parkinsonism.
Language
Korean
URI
http://hdl.handle.net/10371/9569
Files in This Item:
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Dept. of Medicine (의학과)The Seoul Journal of MedicineThe Seoul Journal of Medicine Vol. 25 No.2 (1984)
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse